Serine Peptidase Inhibitor Kazal Type 5 (SPINK5)

[Edit]

LEKTI; LETKI; NETS; NS; VAKTI; Lymphoepithelial Kazal-Type-Related Inhibitor; Lympho-epithelial Kazal-type-related inhibitor

Serine Peptidase Inhibitor Kazal Type 5 (SPINK5)
SPINK5 encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The inhibitor may play a role in skin and hair morphogenesis and anti-inflammatory and/or antimicrobial protection of mucous epithelia. Mutations may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy.The entire precursor protein, as deduced from the nucleotide sequence of the cloned cDNA, includes 15 potential inhibitory domains, 13 of which exhibit a Kazal-type-derived 4-cysteine-residue pattern that represents a novel protein module of serine protease inhibitor. Northern blot analysis and RT-PCR detected expression of LEKTI in thymus, vaginal epithelium, Bartholin gland, oral mucosa, tonsil, and parathyroid gland.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPH145Hu01 Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAH145Hu01 Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) WB; IHC; ICC; IP.
MAH145Hu21 Monoclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) WB
LAH145Hu71 Biotin-Linked Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) WB; IHC; ICC.
Assay Kits SEH145Hu ELISA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPH145Mu01 Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Positive Control; Immunogen; SDS-PAGE; WB.
RPH145Mu02 Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAH145Mu01 Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) WB; IHC; ICC; IP.
PAH145Mu02 Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) WB; IHC; ICC; IP.
Assay Kits SEH145Mu ELISA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) CLIA Kit Customized Service Offer
n/a ELISA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) ELISA Kit Customized Service Offer
  1. "LEKTI, a novel 15-domain type of human serine proteinase inhibitor."J. Biol. Chem. 274:21499-21502(1999) [PubMed] [Europe PMC] [Abstract]
  2. "Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome."Nat. Genet. 25:141-142(2000) [PubMed] [Europe PMC] [Abstract]
  3. "SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing."J. Invest. Dermatol. 126:315-324(2006) [PubMed] [Europe PMC] [Abstract]
  4. "The DNA sequence and comparative analysis of human chromosome 5." Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis."J. Invest. Dermatol. 117:179-187(2001) [PubMed] [Europe PMC] [Abstract]
  6. "Purification and partial amino acid sequence of proteins from human epidermal keratinocyte conditioned medium."J. Protein Chem. 20:273-278(2001) [PubMed] [Europe PMC] [Abstract]
  7. "LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction."Mol. Biol. Cell 18:3607-3619(2007) [PubMed] [Europe PMC] [Abstract]
  8. "New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI."J. Proteome Res. 9:4289-4294(2010) [PubMed] [Europe PMC] [Abstract]
  9. "Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI."J. Mol. Biol. 328:205-219(2003) [PubMed] [Europe PMC] [Abstract]
  10. "The solution structure of a chimeric LEKTI domain reveals a chameleon sequence."Biochemistry 43:11238-11247(2004) [PubMed] [Europe PMC] [Abstract]
  11. "Gene polymorphism in Netherton and common atopic disease."Nat. Genet. 29:175-178(2001) [PubMed] [Europe PMC] [Abstract]